revolade
novartis europharm limited - eltrombopag - púrpura, trombocitopénica, idiopática - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 y 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 y 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.
pemutol 400mg comprimido recubierto
tecnofarma s.a. - droguerÍa - comprimido recubierto - por comprimido - - sofosbuvir
epclusa® 400 mg/100 mg comprimido recubierto
logistics business services s.a.c. - droguerÍa - comprimido recubierto - por comprimido - - sofosbuvir y velpatasvir
sofosbuvir
natco pharma limited. - sofosbuvir - tableta revestida - 400 mg
zepatier comprimidos recubiertos
merck sharp & dohme (i.a.) llc - elbasvir; grazoprevir - sin formulas
daklinza 30 mg 28 comprimits
daklinza 60 mg 28 comprimits
rebetol 40 mg/ml solució oral 100 ml
pegintron 100 mcg 4 plumes precarregades
pegintron 120 mcg 4 plumes precarregades